sglt2 inhibitors and glp-1 receptor agonists Complementary Yet Distinct Roles of in Cardiovascular Risk Reduction SGLT-2 Inhibitors and GLP-1 Agonists:
Description
Sano, M
doi: 10.1007/s40120-025-00724-y
(pensive music) Hey, smart people
therefore, it does not require ethical approval from an Institutional Review Board (IRB) or participant consent
For A 25-35 -treated mice, liraglutide dose-dependently prevented against A 25-35 -induced impairment of spatial learning and memory, prevented depression of hippocampal L-LTP, and upregulated intracellular cAMP level (177)
A 56-week trial included 422 patients with BMI30 kg/m 2 or BMI27 kg/m 2 with dyslipidemia and/or hypertension (non-diabetic)
